• +91 9169164321 (Asia)
  • +1(646)-781-7170 (Int'l)
  • help@24lifesciences.com
Cart (0)

Global Hormone Refractory Prostate Cancer Market Size, Status and Forecast 2020-2026

report cover
  • 31 July 2020
  • Pharmaceuticals
  • 95 Pages
  • Report Code: 24LS-16410
  • Formate :   
Download FREE Report Sample Download PDF File

Hormone Refractory Prostate Cancer -MARKET ADVISORY SERVICES

Hormone Refractory Prostate Cancer market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Hormone Refractory Prostate Cancer market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
Astellas Inc
Sanofi S.A
Dendreon Corporation, Bayer AG
Johnson & Johnson
...

Market segment by Type, the product can be split into
Chemotherapy
Hormonal Therapy
Immunotherapy
Radiation Therapy
Surgery
Market segment by Application, split into
Hospitals
Ambulatory Surgical Centers
Specialty Clinics

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Hormone Refractory Prostate Cancer Revenue
1.4 Market by Type
1.4.1 Global Hormone Refractory Prostate Cancer Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Chemotherapy
1.4.3 Hormonal Therapy
1.4.4 Immunotherapy
1.4.5 Radiation Therapy
1.4.6 Surgery
1.5 Market by Application
1.5.1 Global Hormone Refractory Prostate Cancer Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Ambulatory Surgical Centers
1.5.4 Specialty Clinics
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global Hormone Refractory Prostate Cancer Market Perspective (2015-2026)
2.2 Global Hormone Refractory Prostate Cancer Growth Trends by Regions
2.2.1 Hormone Refractory Prostate Cancer Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Hormone Refractory Prostate Cancer Historic Market Share by Regions (2015-2020)
2.2.3 Hormone Refractory Prostate Cancer Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Hormone Refractory Prostate Cancer Market Growth Strategy
2.3.6 Primary Interviews with Key Hormone Refractory Prostate Cancer Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Hormone Refractory Prostate Cancer Players by Market Size
3.1.1 Global Top Hormone Refractory Prostate Cancer Players by Revenue (2015-2020)
3.1.2 Global Hormone Refractory Prostate Cancer Revenue Market Share by Players (2015-2020)
3.1.3 Global Hormone Refractory Prostate Cancer Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Hormone Refractory Prostate Cancer Market Concentration Ratio
3.2.1 Global Hormone Refractory Prostate Cancer Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Hormone Refractory Prostate Cancer Revenue in 2019
3.3 Hormone Refractory Prostate Cancer Key Players Head office and Area Served
3.4 Key Players Hormone Refractory Prostate Cancer Product Solution and Service
3.5 Date of Enter into Hormone Refractory Prostate Cancer Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Hormone Refractory Prostate Cancer Historic Market Size by Type (2015-2020)
4.2 Global Hormone Refractory Prostate Cancer Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global Hormone Refractory Prostate Cancer Market Size by Application (2015-2020)
5.2 Global Hormone Refractory Prostate Cancer Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Hormone Refractory Prostate Cancer Market Size (2015-2020)
6.2 Hormone Refractory Prostate Cancer Key Players in North America (2019-2020)
6.3 North America Hormone Refractory Prostate Cancer Market Size by Type (2015-2020)
6.4 North America Hormone Refractory Prostate Cancer Market Size by Application (2015-2020)

7 Europe
7.1 Europe Hormone Refractory Prostate Cancer Market Size (2015-2020)
7.2 Hormone Refractory Prostate Cancer Key Players in Europe (2019-2020)
7.3 Europe Hormone Refractory Prostate Cancer Market Size by Type (2015-2020)
7.4 Europe Hormone Refractory Prostate Cancer Market Size by Application (2015-2020)

8 China
8.1 China Hormone Refractory Prostate Cancer Market Size (2015-2020)
8.2 Hormone Refractory Prostate Cancer Key Players in China (2019-2020)
8.3 China Hormone Refractory Prostate Cancer Market Size by Type (2015-2020)
8.4 China Hormone Refractory Prostate Cancer Market Size by Application (2015-2020)

9 Japan
9.1 Japan Hormone Refractory Prostate Cancer Market Size (2015-2020)
9.2 Hormone Refractory Prostate Cancer Key Players in Japan (2019-2020)
9.3 Japan Hormone Refractory Prostate Cancer Market Size by Type (2015-2020)
9.4 Japan Hormone Refractory Prostate Cancer Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Hormone Refractory Prostate Cancer Market Size (2015-2020)
10.2 Hormone Refractory Prostate Cancer Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Hormone Refractory Prostate Cancer Market Size by Type (2015-2020)
10.4 Southeast Asia Hormone Refractory Prostate Cancer Market Size by Application (2015-2020)

11 India
11.1 India Hormone Refractory Prostate Cancer Market Size (2015-2020)
11.2 Hormone Refractory Prostate Cancer Key Players in India (2019-2020)
11.3 India Hormone Refractory Prostate Cancer Market Size by Type (2015-2020)
11.4 India Hormone Refractory Prostate Cancer Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Hormone Refractory Prostate Cancer Market Size (2015-2020)
12.2 Hormone Refractory Prostate Cancer Key Players in Central & South America (2019-2020)
12.3 Central & South America Hormone Refractory Prostate Cancer Market Size by Type (2015-2020)
12.4 Central & South America Hormone Refractory Prostate Cancer Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 Astellas Inc
13.1.1 Astellas Inc Company Details
13.1.2 Astellas Inc Business Overview
13.1.3 Astellas Inc Hormone Refractory Prostate Cancer Introduction
13.1.4 Astellas Inc Revenue in Hormone Refractory Prostate Cancer Business (2015-2020))
13.1.5 Astellas Inc Recent Development
13.2 Sanofi S.A
13.2.1 Sanofi S.A Company Details
13.2.2 Sanofi S.A Business Overview
13.2.3 Sanofi S.A Hormone Refractory Prostate Cancer Introduction
13.2.4 Sanofi S.A Revenue in Hormone Refractory Prostate Cancer Business (2015-2020)
13.2.5 Sanofi S.A Recent Development
13.3 Dendreon Corporation, Bayer AG
13.3.1 Dendreon Corporation, Bayer AG Company Details
13.3.2 Dendreon Corporation, Bayer AG Business Overview
13.3.3 Dendreon Corporation, Bayer AG Hormone Refractory Prostate Cancer Introduction
13.3.4 Dendreon Corporation, Bayer AG Revenue in Hormone Refractory Prostate Cancer Business (2015-2020)
13.3.5 Dendreon Corporation, Bayer AG Recent Development
13.4 Johnson & Johnson
13.4.1 Johnson & Johnson Company Details
13.4.2 Johnson & Johnson Business Overview
13.4.3 Johnson & Johnson Hormone Refractory Prostate Cancer Introduction
13.4.4 Johnson & Johnson Revenue in Hormone Refractory Prostate Cancer Business (2015-2020)
13.4.5 Johnson & Johnson Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
List of Tables

Table 1. Hormone Refractory Prostate Cancer Key Market Segments

Table 2. Key Players Covered: Ranking by Hormone Refractory Prostate Cancer Revenue

Table 3. Ranking of Global Top Hormone Refractory Prostate Cancer Manufacturers by Revenue (US$ Million) in 2019

Table 4. Global Hormone Refractory Prostate Cancer Market Size Growth Rate by Type (US$ Million): 2020 VS 2026

Table 5. Key Players of Chemotherapy

Table 6. Key Players of Hormonal Therapy

Table 7. Key Players of Immunotherapy

Table 8. Key Players of Radiation Therapy

Table 9. Key Players of Surgery

Table 10. Global Hormone Refractory Prostate Cancer Market Size Growth by Application (US$ Million): 2020 VS 2026

Table 11. Global Hormone Refractory Prostate Cancer Market Size by Regions (US$ Million): 2020 VS 2026

Table 12. Global Hormone Refractory Prostate Cancer Market Size by Regions (2015-2020) (US$ Million)

Table 13. Global Hormone Refractory Prostate Cancer Market Share by Regions (2015-2020)

Table 14. Global Hormone Refractory Prostate Cancer Forecasted Market Size by Regions (2021-2026) (US$ Million)

Table 15. Global Hormone Refractory Prostate Cancer Market Share by Regions (2021-2026)

Table 16. Market Top Trends

Table 17. Key Drivers: Impact Analysis

Table 18. Key Challenges

Table 19. Hormone Refractory Prostate Cancer Market Growth Strategy

Table 20. Main Points Interviewed from Key Hormone Refractory Prostate Cancer Players

Table 21. Global Hormone Refractory Prostate Cancer Revenue by Players (2015-2020) (Million US$)

Table 22. Global Hormone Refractory Prostate Cancer Market Share by Players (2015-2020)

Table 23. Global Top Hormone Refractory Prostate Cancer Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hormone Refractory Prostate Cancer as of 2019)

Table 24. Global Hormone Refractory Prostate Cancer by Players Market Concentration Ratio (CR5 and HHI)

Table 25. Key Players Headquarters and Area Served

Table 26. Key Players Hormone Refractory Prostate Cancer Product Solution and Service

Table 27. Date of Enter into Hormone Refractory Prostate Cancer Market

Table 28. Mergers & Acquisitions, Expansion Plans

Table 29. Global Hormone Refractory Prostate Cancer Market Size by Type (2015-2020) (Million US$)

Table 30. Global Hormone Refractory Prostate Cancer Market Size Share by Type (2015-2020)

Table 31. Global Hormone Refractory Prostate Cancer Revenue Market Share by Type (2021-2026)

Table 32. Global Hormone Refractory Prostate Cancer Market Size Share by Application (2015-2020)

Table 33. Global Hormone Refractory Prostate Cancer Market Size by Application (2015-2020) (Million US$)

Table 34. Global Hormone Refractory Prostate Cancer Market Size Share by Application (2021-2026)

Table 35. North America Key Players Hormone Refractory Prostate Cancer Revenue (2019-2020) (Million US$)

Table 36. North America Key Players Hormone Refractory Prostate Cancer Market Share (2019-2020)

Table 37. North America Hormone Refractory Prostate Cancer Market Size by Type (2015-2020) (Million US$)

Table 38. North America Hormone Refractory Prostate Cancer Market Share by Type (2015-2020)

Table 39. North America Hormone Refractory Prostate Cancer Market Size by Application (2015-2020) (Million US$)

Table 40. North America Hormone Refractory Prostate Cancer Market Share by Application (2015-2020)

Table 41. Europe Key Players Hormone Refractory Prostate Cancer Revenue (2019-2020) (Million US$)

Table 42. Europe Key Players Hormone Refractory Prostate Cancer Market Share (2019-2020)

Table 43. Europe Hormone Refractory Prostate Cancer Market Size by Type (2015-2020) (Million US$)

Table 44. Europe Hormone Refractory Prostate Cancer Market Share by Type (2015-2020)

Table 45. Europe Hormone Refractory Prostate Cancer Market Size by Application (2015-2020) (Million US$)

Table 46. Europe Hormone Refractory Prostate Cancer Market Share by Application (2015-2020)

Table 47. China Key Players Hormone Refractory Prostate Cancer Revenue (2019-2020) (Million US$)

Table 48. China Key Players Hormone Refractory Prostate Cancer Market Share (2019-2020)

Table 49. China Hormone Refractory Prostate Cancer Market Size by Type (2015-2020) (Million US$)

Table 50. China Hormone Refractory Prostate Cancer Market Share by Type (2015-2020)

Table 51. China Hormone Refractory Prostate Cancer Market Size by Application (2015-2020) (Million US$)

Table 52. China Hormone Refractory Prostate Cancer Market Share by Application (2015-2020)

Table 53. Japan Key Players Hormone Refractory Prostate Cancer Revenue (2019-2020) (Million US$)

Table 54. Japan Key Players Hormone Refractory Prostate Cancer Market Share (2019-2020)

Table 55. Japan Hormone Refractory Prostate Cancer Market Size by Type (2015-2020) (Million US$)

Table 56. Japan Hormone Refractory Prostate Cancer Market Share by Type (2015-2020)

Table 57. Japan Hormone Refractory Prostate Cancer Market Size by Application (2015-2020) (Million US$)

Table 58. Japan Hormone Refractory Prostate Cancer Market Share by Application (2015-2020)

Table 59. Southeast Asia Key Players Hormone Refractory Prostate Cancer Revenue (2019-2020) (Million US$)

Table 60. Southeast Asia Key Players Hormone Refractory Prostate Cancer Market Share (2019-2020)

Table 61. Southeast Asia Hormone Refractory Prostate Cancer Market Size by Type (2015-2020) (Million US$)

Table 62. Southeast Asia Hormone Refractory Prostate Cancer Market Share by Type (2015-2020)

Table 63. Southeast Asia Hormone Refractory Prostate Cancer Market Size by Application (2015-2020) (Million US$)

Table 64. Southeast Asia Hormone Refractory Prostate Cancer Market Share by Application (2015-2020)

Table 65. India Key Players Hormone Refractory Prostate Cancer Revenue (2019-2020) (Million US$)

Table 66. India Key Players Hormone Refractory Prostate Cancer Market Share (2019-2020)

Table 67. India Hormone Refractory Prostate Cancer Market Size by Type (2015-2020) (Million US$)

Table 68. India Hormone Refractory Prostate Cancer Market Share by Type (2015-2020)

Table 69. India Hormone Refractory Prostate Cancer Market Size by Application (2015-2020) (Million US$)

Table 70. India Hormone Refractory Prostate Cancer Market Share by Application (2015-2020)

Table 71. Central & South America Key Players Hormone Refractory Prostate Cancer Revenue (2019-2020) (Million US$)

Table 72. Central & South America Key Players Hormone Refractory Prostate Cancer Market Share (2019-2020)

Table 73. Central & South America Hormone Refractory Prostate Cancer Market Size by Type (2015-2020) (Million US$)

Table 74. Central & South America Hormone Refractory Prostate Cancer Market Share by Type (2015-2020)

Table 75. Central & South America Hormone Refractory Prostate Cancer Market Size by Application (2015-2020) (Million US$)

Table 76. Central & South America Hormone Refractory Prostate Cancer Market Share by Application (2015-2020)

Table 77. Astellas Inc Company Details

Table 78. Astellas Inc Business Overview

Table 79. Astellas Inc Product

Table 80. Astellas Inc Revenue in Hormone Refractory Prostate Cancer Business (2015-2020) (Million US$)

Table 81. Astellas Inc Recent Development

Table 82. Sanofi S.A Company Details

Table 83. Sanofi S.A Business Overview

Table 84. Sanofi S.A Product

Table 85. Sanofi S.A Revenue in Hormone Refractory Prostate Cancer Business (2015-2020) (Million US$)

Table 86. Sanofi S.A Recent Development

Table 87. Dendreon Corporation, Bayer AG Company Details

Table 88. Dendreon Corporation, Bayer AG Business Overview

Table 89. Dendreon Corporation, Bayer AG Product

Table 90. Dendreon Corporation, Bayer AG Revenue in Hormone Refractory Prostate Cancer Business (2015-2020) (Million US$)

Table 91. Dendreon Corporation, Bayer AG Recent Development

Table 92. Johnson & Johnson Company Details

Table 93. Johnson & Johnson Business Overview

Table 94. Johnson & Johnson Product

Table 95. Johnson & Johnson Revenue in Hormone Refractory Prostate Cancer Business (2015-2020) (Million US$)

Table 96. Johnson & Johnson Recent Development

Table 97. Research Programs/Design for This Report

Table 98. Key Data Information from Secondary Sources

Table 99. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Hormone Refractory Prostate Cancer Market Share by Type: 2020 VS 2026

Figure 2. Chemotherapy Features

Figure 3. Hormonal Therapy Features

Figure 4. Immunotherapy Features

Figure 5. Radiation Therapy Features

Figure 6. Surgery Features

Figure 7. Global Hormone Refractory Prostate Cancer Market Share by Application: 2020 VS 2026

Figure 8. Hospitals Case Studies

Figure 9. Ambulatory Surgical Centers Case Studies

Figure 10. Specialty Clinics Case Studies

Figure 11. Hormone Refractory Prostate Cancer Report Years Considered

Figure 12. Global Hormone Refractory Prostate Cancer Market Size YoY Growth 2015-2026 (US$ Million)

Figure 13. Global Hormone Refractory Prostate Cancer Market Share by Regions: 2020 VS 2026

Figure 14. Global Hormone Refractory Prostate Cancer Market Share by Regions (2021-2026)

Figure 15. Porter's Five Forces Analysis

Figure 16. Global Hormone Refractory Prostate Cancer Market Share by Players in 2019

Figure 17. Global Top Hormone Refractory Prostate Cancer Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hormone Refractory Prostate Cancer as of 2019

Figure 18. The Top 10 and 5 Players Market Share by Hormone Refractory Prostate Cancer Revenue in 2019

Figure 19. North America Hormone Refractory Prostate Cancer Market Size YoY Growth (2015-2020) (Million US$)

Figure 20. Europe Hormone Refractory Prostate Cancer Market Size YoY Growth (2015-2020) (Million US$)

Figure 21. China Hormone Refractory Prostate Cancer Market Size YoY Growth (2015-2020) (Million US$)

Figure 22. Japan Hormone Refractory Prostate Cancer Market Size YoY Growth (2015-2020) (Million US$)

Figure 23. Southeast Asia Hormone Refractory Prostate Cancer Market Size YoY Growth (2015-2020) (Million US$)

Figure 24. India Hormone Refractory Prostate Cancer Market Size YoY Growth (2015-2020) (Million US$)

Figure 25. Central & South America Hormone Refractory Prostate Cancer Market Size YoY Growth (2015-2020) (Million US$)

Figure 26. Bottom-up and Top-down Approaches for This Report

Figure 27. Data Triangulation

Figure 28. Key Executives Interviewed

Astellas Inc

Sanofi S.A

Dendreon Corporation, Bayer AG

Johnson & Johnson

CHOOSE YOUR BUYING OPTION COVID-19 Revised Pricing Of the Month

SECURITY ASSUREDpayment image

Frequently Asked Questions ?

  • A license granted to one user.

    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License

    A license granted to multiple users.

  • Site License

    A license granted to a single business site/establishment.

  • Corporate License, Global License

    A license granted to all employees within organisation access to the product.

  • Upto Working 24 to 48 hrs

  • Upto 72 hrs max - Weekends and Public Holidays

  • Online Payments with PayPal and CCavenue

  • Wire Transfer/Bank Transfer

  • Email

  • Hard Copy

CHECK TODAYS BEST PRICE

BEST PRICE: $3198

SOME OF OUR CLIENTS

OUR KEY POINTS

  • Comprehensive Research

    Offers Penetrative insights & holistic understanding of the market

  • Data Accuracy & Reliability

    Strictly follows the Research Meth-odology for flawless results

  • Competitive Pricing

    Ensure the best and affordable pricing

  • Security & Confidentiality

    All your transactions are secured end-to-end, ensuring a satisfactory purchase